The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 Peptide Therapy Doctors Supplement Store GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with